Vigorous physical activity associated with reduced risk of psoriasis – A study of U.S. women suggests that vigorous physical activity may be associated with a reduced risk of psoriasis. Psoriasis is an immunologic disorder characterized by systemic inflammation and scaling of the skin.
Certain drugs lower risk of diabetes for patients with rheumatoid arthritis or psoriasis – Certain rheumatoid arthritis and psoriasis medications are associated with reduced diabetes risk, revealed by researchers. 2 disease-modifying antirheumatic drugs, TNF inhibitors and hydroxychloroquine, are associated with a reduced risk for the development of diabetes in psoriasis and rheumatoid arthritis patients
Features of the metabolic syndrome common in persons with psoriasis – Individuals with psoriasis have a high prevalence of the metabolic syndrome, according to a report that will appear in the April_2011 print issue of Archives of Dermatology.
Women who drink beer more likely to develop psoriasis – Regular beer – but not light beer or other types of alcohol – appears to be associated with an increased risk of developing psoriasis, revealed by researchers.
Psoriasis associated with cardiovascular disease and increased mortality – Psoriasis skin disease is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, revealed by researchers.
In this prospective analysis, psoriasis was independently associated with an increased risk of diabetes and hypertension. Future studies are needed to find out whether psoriasis treatment will reduce the risk of diabetes and hypertension. – Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the JAMA/Archives journals.
US FDA Approves Updated Labeling for Psoriasis Drug Raptiva by Genentech; Safety concerns drove labeling changes. – The U.S. Food and Drug Administration announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephalopathy (PML), with the use of Raptiva (efalizumab).
Etanercept (Enbrel) significantly reduces psoriasis disease severity in children and adolescents with moderate-to-severe plaque psoriasis. – A Phase 3 study showed that children and adolescents with moderate to severe plaque psoriasis who received treatment with Enbrel experienced significant improvements in the signs and symptoms of their disease psoriasis.
People with a severe form of the skin disease psoriasis are likely to die at a younger age than their healthy peers, according to a study at the University of Pennsylvania School of Medicine, Philadelphia. – Patients with severe psoriasis appear to have an increased risk of death compared with patients without the skin condition, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals.